subscribeSubscribe
Pfenex and NT Pharma Enter Dev &License Agreement for Pfenex`s PF708 to Forteo®

Pfenex and NT Pharma Enter Dev &License Agreement for Pfenex`s PF708 to Forteo®
PR NEWSWIRE
18 Apr 2018
Share Share
Forteo®(Teriparatide) : Eli Lilly And Company v. Apotex

Forteo®(Teriparatide) : Eli Lilly And Company v. Apotex
PATENT LITIGATION
04 Apr 2018
Share Share
FDA Denies Amneal Petition Seeking to Block Generic Versions of Osteoporosis

FDA Denies Amneal Petition Seeking to Block Generic Versions of Osteoporosis
Zachary Brennan RAPS
09 Jan 2018
Share Share
New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk

New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk
PR NEWSWIRE
09 Nov 2017
Share Share
The Indian Peptides and Heparin Market Worth 883.0 Million & 170.2 Million

The Indian Peptides and Heparin Market Worth 883.0 Million & 170.2 Million
PR NEWSWIRE
21 Aug 2017
Share Share
Gedeon Richter Plc Terrosa (teriparatide) Receives Approval In Europe

Gedeon Richter Plc Terrosa (teriparatide) Receives Approval In Europe
EMA
05 May 2017
Share Share
Gedeon Richter Terrosa (Teriparatide) Receives Approval In Europe

Gedeon Richter Terrosa (Teriparatide) Receives Approval In Europe
EMA
16 Mar 2017
Share Share
STADA Arzneimittel Movymia (Teriparatide) Receives Approval In Europe

STADA Arzneimittel Movymia (Teriparatide) Receives Approval In Europe
EMA
16 Mar 2017
Share Share
Glide raises £3.2m for solid dose injector programme

Glide raises £3.2m for solid dose injector programme
Selina McKee PHARMATIMES
02 Feb 2017
Share Share
Nine Therapies Put Forward for EU Approval

Nine Therapies Put Forward for EU Approval
Selina McKee PHARMATIMES
15 Nov 2016
Share Share